Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)

✍ Scribed by John B Buse; Julio Rosenstock; Giorgio Sesti; Wolfgang E Schmidt; Eduard Montanya; Jason H Brett; Marcin Zychma; Lawrence Blonde

• Book ID: 117304668
• Publisher: The Lancet
• Year: 2009
• Tongue: English
• Weight: 244 KB
• Volume: 374
• Category: Article
• ISSN: 0140-6736
• DOI: 10.1016/s0140-6736(09)60659-0